Anti-EID2B antibodies are used in the immunodetection of the protein EP300 interacting inhibitor of differentiation 2B. In humans, the canonical protein has a reported length of 161 amino acid residues and a mass of 17 kDa. Its subcellular localization is in the nucleus. It is notably widely expressed in many tissue types. EID2B is known to act as a repressor of MYOD-dependent transcription, glucocorticoid receptor-dependent transcription, and muscle differentiation. Synonyms for this target antigen include EID-2-like inhibitor of differentiation-3. EID2B gene orthologs have been reported in the mouse, rat and chimpanzee species. Indicated applications for EID2B antibodies listed below include ELISA, Western Blot, and Immunohistochemistry.